NASDAQ · DXR

Daxor Corp

Closing price · Nov 13, 2026 $8.48
Last insider buy price $9.07 Paid by CEO, Director Michael Feldschuh on Apr 8, 2026 (Form 4). Not today's price.

Latest quarter · ended Dec 31, 2011

Cash got weaker, but sales grew

descriptionFiled Mar 28, 2012
Revenue growthFaster
+2.3%
Quarter ended Jun 30, 2011: −2.8% sales vs. a year beforeQuarter ended Sep 30, 2011: −24.8% sales vs. a year beforeQuarter ended Dec 31, 2011: +2.3% sales vs. a year before
Jun '11Dec '11
$370K vs. $361K a year ago
Gross marginBetter
52.2%
Quarter ended Jun 30, 2010: 55.1% gross marginQuarter ended Sep 30, 2010: 59.0% gross marginQuarter ended Dec 31, 2010: 48.9% gross marginQuarter ended Jun 30, 2011: 55.1% gross marginQuarter ended Sep 30, 2011: 56.2% gross marginQuarter ended Dec 31, 2011: 52.2% gross margin
Jun '10Dec '11
vs. 48.9% a year ago
Cash from operationsBetter
−$990K
Quarter ended Sep 30, 2010: −$1.22M cash from operationsQuarter ended Dec 31, 2010: −$1.84M cash from operationsQuarter ended Sep 30, 2011: −$613K cash from operationsQuarter ended Dec 31, 2011: −$990K cash from operations
Sep '10Dec '11
vs. −$1.84M a year ago
Share countSteady
−0.7%
Quarter ended Jun 30, 2010: 4.22M sharesQuarter ended Sep 30, 2010: 4.22M sharesQuarter ended Dec 31, 2010: 4.22M sharesQuarter ended Jun 30, 2011: 4.22M sharesQuarter ended Sep 30, 2011: 4.21M sharesQuarter ended Dec 31, 2011: 4.2M shares
Jun '10Dec '11
4.2M shares vs. 4.22M a year ago

Numbers come from the company's own 10-Q and 10-K reports filed with the SEC. Each bar is one quarter, oldest on the left. The colored bar is the latest. Hover over or tap a bar to see its number.

Smart money pulse

What insiders and funds are doing

Buying Insiders: as of Nov 13 Funds: as of Jun 30, 2026
−1000+100 +50
  • account_balance
    1 fund bought, 0 sold in the quarter ended Jun 30, 2026, counting funds that hold 500 stocks or fewer and $1M+ of this one. Index funds and banks are left out.
  • info
    No real insider sales in 12 months. Planned 10b5-1 sales and tax withholding are left out.

−100 means everyone selling, +100 everyone buying. This is data, not advice.

How the Pulse works

Pulse runs from −100 (everyone selling) to +100 (everyone buying). Half comes from insiders: real buyers vs. real sellers in the last 90 days (Form 4). Half comes from funds: funds that bought vs. funds that sold last quarter (13F). 13F is a snapshot of long positions on the last day of the quarter, filed up to 45 days later. It does not show short positions or trades since then.

Who owns it

17 funds report owning DXR, up from 16

Holdings as of Jun 30, 2026
New3
Added5
Held9
Trimmed0
Sold out1

Last quarter

Who bought and who sold

Apr–Jun 2026
Thompson Siegel & Walmsley LLC
+4%

Change in shares held from Mar 31 to Jun 30, 2026, biggest holdings first. Only funds that hold 500 stocks or fewer and $1M+ of this one: index funds and banks own almost everything, so their changes say little. Bars stop at ±100%.

Insider trades · last 12 months

Real buys and sales

● Open-market buy● Open-market sale
CEOCFOOther officersDirectorsDecJanFebMarAprMayJunJulAugSepOctNovStock grant · Jun 23 · 25,000 shStock grant · Jun 23 · 30,000 shStock grant · Jun 23 · 12,000 shStock grant · Aug 28 · 2,451 shOpen-market buy · Dec 9 · 18,000 shOpen-market buy · Dec 9 · 3,000 shOpen-market buy · Mar 20 · 5,941 shOpen-market buy · Mar 31 · $9.9KOpen-market buy · Apr 8 · $9.07K
CEOCFOOther officersDirectorsDecFebAprJunAugOctStock grant · Jun 23 · 25,000 shStock grant · Jun 23 · 30,000 shStock grant · Jun 23 · 12,000 shStock grant · Aug 28 · 2,451 shOpen-market buy · Dec 9 · 18,000 shOpen-market buy · Dec 9 · 3,000 shOpen-market buy · Mar 20 · 5,941 shOpen-market buy · Mar 31 · $9.9KOpen-market buy · Apr 8 · $9.07K

Last 12 months. No real trades in the last 6.

Showing 5 real trades. Hidden: 4 stock grants. Those happen on a schedule and say little about what an insider thinks. Bigger dot means a bigger trade.

Real trades, newest first

Apr 8 Michael Feldschuh Past buys: 2 of 4 beat CEO, Director Open-market buy $9.07K 1,000 sh at $9.07
Mar 31 Robert Michel Past buys: 2 of 4 beat CFO Open-market buy $9.9K 1,000 sh at $9.90
Mar 20 John Jefferies Chief Medical Officer Open-market buy $0 5,941 sh at $0.00
Dec 9 Jonathan Feldschuh Chief Scientific Officer, Director Open-market buy $0 18,000 sh at $0.00
Dec 9 Robert Michel Past buys: 2 of 4 beat CFO Open-market buy $0 3,000 sh at $0.00

"Past buys: 2 of 3 beat" means this insider bought stock in 3 earlier quarters, and in 2 of them what they bought did better than the typical stock over the next 6 months. A past record is data, not a forecast.

Showing every filing. Dashed circles are routine: grants, tax withholding, option exercises and planned sales.

Top holders

Biggest funds in DXR

As of Jun 30, 2026
FundOwnsValueChange
Thompson Siegel & Walmsley LLC5.8%$2.49M+4%
Vanguard Capital Management LLC1.2%$496K+1%
Aristides Capital LLC1.0%$429KSame
BFC Planning, Inc.0.9%$378KSame
Renaissance Technologies LLC0.7%$303K+5%

"Owns" is shares reported divided by shares outstanding.

Where this data comes from. Insider trades, fund holdings, activist stakes and company results come from public SEC EDGAR filings (Forms 4, 13F, 13D/13G, 10-Q and 8-K). Congress trades come from the STOCK Act reports members file with the House Clerk and the Senate. Daily closing prices come from post-no-preference/stocks on DoltHub, a community-run database shared under CC BY-SA 4.0; the prices we show stay under that license. They are each day's close, not live or official exchange prices.

This is data, not investment advice. About StockToast